Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27718847

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2016 Nov 10
First author
Reck M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2016 Nov 10;375(19):1892-1893. doi: 10.1056/NEJMe1611003.
    note
    Source null
    related pmid
    27718875
    relationship
    Comment in
  2. citation
    Expert Rev Anticancer Ther. 2017 Mar;17(3):199-201. doi: 10.1080/14737140.2017.1286986.
    note
    Source null
    related pmid
    28129007
    relationship
    Comment in
  3. citation
    N Engl J Med. ;376(10):996-7. doi: 10.1056/NEJMc1615559.
    note
    Source null
    related pmid
    28276230
    relationship
    Comment in
  4. citation
    Ann Transl Med. 2017 Apr;5(7):166. doi: 10.21037/atm.2017.03.55.
    note
    Source null
    related pmid
    28480202
    relationship
    Comment in
  5. citation
    J Thorac Dis. 2017 Apr;9(4):E384-E386. doi: 10.21037/jtd.2017.03.118.
    note
    Source null
    related pmid
    28523184
    relationship
    Comment in
  6. citation
    J Thorac Dis. 2017 May;9(5):E519-E521. doi: 10.21037/jtd.2017.03.155.
    note
    Source null
    related pmid
    28616326
    relationship
    Comment in
  7. citation
    Am J Respir Crit Care Med. 2018 Sep 1;198(5):667-669. doi: 10.1164/rccm.201801-0107RR.
    note
    Source null
    related pmid
    29966101
    relationship
    Comment in
  8. citation
    Transl Cancer Res. 2017 Feb;6(Suppl 1):S151-S157. doi: 10.21037/tcr.2017.02.28.
    note
    Source null
    related pmid
    30613479
    relationship
    Comment in

Authors and identifiers

  1. name
    Reck M
    type
    Author
  2. name
    Rodríguez-Abreu D
    type
    Author
  3. name
    Robinson AG
    type
    Author
  4. name
    Hui R
    type
    Author
  5. name
    Csőszi T
    type
    Author
  6. name
    Fülöp A
    type
    Author
  7. name
    Gottfried M
    type
    Author
  8. name
    Peled N
    type
    Author
  9. name
    Tafreshi A
    type
    Author
  10. name
    Cuffe S
    type
    Author
  11. name
    O'Brien M
    type
    Author
  12. name
    Rao S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Reck M
    type
    Author
  2. name
    Rodríguez-Abreu D
    type
    Author
  3. name
    Robinson AG
    type
    Author
  4. name
    Hui R
    type
    Author
  5. name
    Csőszi T
    type
    Author
  6. name
    Fülöp A
    type
    Author
  7. name
    Gottfried M
    type
    Author
  8. name
    Peled N
    type
    Author
  9. name
    Tafreshi A
    type
    Author
  10. name
    Cuffe S
    type
    Author
  11. name
    O'Brien M
    type
    Author
  12. name
    Rao S
    type
    Author
bibliography ids
  1. nci-bib-40f44d1e5114265632a135d1
book metadata
content sha256
23ee6a2d2d815f1420e4901138c63a5a86f3b84d84e25d6641d4ff8953669ddb
document type
citation
dois
  1. 10.1056/NEJMoa1606774
electronic publication date
display
2016 Oct 8
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27718847
immutable id
pubmed:27718847@23ee6a2d2d815f1420e4901138c63a5a86f3b84d84e25d6641d4ff8953669ddb
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
19
name
The New England journal of medicine
nlm unique id
0255562
pages
1823-1833
volume
375
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2016 Nov 10;375(19):1892-1893. doi: 10.1056/NEJMe1611003.
    note
    Source null
    related pmid
    27718875
    relationship
    Comment in
  2. citation
    Expert Rev Anticancer Ther. 2017 Mar;17(3):199-201. doi: 10.1080/14737140.2017.1286986.
    note
    Source null
    related pmid
    28129007
    relationship
    Comment in
  3. citation
    N Engl J Med. ;376(10):996-7. doi: 10.1056/NEJMc1615559.
    note
    Source null
    related pmid
    28276230
    relationship
    Comment in
  4. citation
    Ann Transl Med. 2017 Apr;5(7):166. doi: 10.21037/atm.2017.03.55.
    note
    Source null
    related pmid
    28480202
    relationship
    Comment in
  5. citation
    J Thorac Dis. 2017 Apr;9(4):E384-E386. doi: 10.21037/jtd.2017.03.118.
    note
    Source null
    related pmid
    28523184
    relationship
    Comment in
  6. citation
    J Thorac Dis. 2017 May;9(5):E519-E521. doi: 10.21037/jtd.2017.03.155.
    note
    Source null
    related pmid
    28616326
    relationship
    Comment in
  7. citation
    Am J Respir Crit Care Med. 2018 Sep 1;198(5):667-669. doi: 10.1164/rccm.201801-0107RR.
    note
    Source null
    related pmid
    29966101
    relationship
    Comment in
  8. citation
    Transl Cancer Res. 2017 Feb;6(Suppl 1):S151-S157. doi: 10.21037/tcr.2017.02.28.
    note
    Source null
    related pmid
    30613479
    relationship
    Comment in
outcomes validated
false
pmid
27718847
provenance
batch id
d649bcb2d98dbbacd53c
provider
NCBI PubMed ESummary
record sha256
50e092a42463661e82dfe48c7e74be7d329e3e0803c00a33527643f1a9e7fe2e
response sha256
26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
retrieved at
2026-09-09T23:47:20.761544+00:00
publication date
display
2016 Nov 10
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27718847/
title
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Preserved source evidence · Not medical advice